Publicacions en què col·labora amb Dzmitry G. Shcharbin (30)

2021

  1. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells

    Dalton Transactions, Vol. 50, Núm. 27, pp. 9500-9511

  2. Comparison of the effects of dendrimer, micelle and silver nanoparticles on phospholipase A2 structure

    Journal of Biotechnology, Vol. 331, pp. 48-52

  3. Evaluation of dendronized gold nanoparticles as siRNAs carriers into cancer cells

    Journal of Molecular Liquids, Vol. 324

  4. Prospects of cationic carbosilane dendronized gold nanoparticles as non-viral vectors for delivery of anticancer sirnas sibcl-xl and simcl-1

    Pharmaceutics, Vol. 13, Núm. 10

2020

  1. Effect of PEGylation on the biological properties of cationic carbosilane dendronized gold nanoparticles

    International Journal of Pharmaceutics, Vol. 573

  2. Generation dependent effects and entrance to mitochondria of hybrid dendrimers on normal and cancer neuronal cells in vitro

    Biomolecules, Vol. 10, Núm. 3

  3. Ruthenium dendrimers against human lymphoblastic leukemia 1301 cells

    International Journal of Molecular Sciences, Vol. 21, Núm. 11, pp. 1-13

2019

  1. Complexes of pro-apoptotic sirnas and carbosilane dendrimers: Formation and effect on cancer cells

    Pharmaceutics, Vol. 11, Núm. 1

  2. Ruthenium dendrimers against acute promyelocytic leukemia: In vitro studies on HL-60 cells

    Future Medicinal Chemistry, Vol. 11, Núm. 14, pp. 1741-1756

  3. Synthesis and characterization of FITC labelled ruthenium dendrimer as a prospective anticancer drug

    Biomolecules, Vol. 9, Núm. 9

2018

  1. Dendronization of gold nanoparticles decreases their effect on human alpha-1-microglobulin

    International Journal of Biological Macromolecules, Vol. 108, pp. 936-941

  2. Role of cationic carbosilane dendrons and metallic core of functionalized gold nanoparticles in their interaction with human serum albumin

    International Journal of Biological Macromolecules, Vol. 118, pp. 1773-1780

  3. Ruthenium dendrimers as carriers for anticancer siRNA

    Journal of Inorganic Biochemistry, Vol. 181, pp. 18-27

2017

  1. Binding of poly(amidoamine), carbosilane, phosphorus and hybrid dendrimers to thrombin—Constants and mechanisms

    Colloids and Surfaces B: Biointerfaces, Vol. 155, pp. 11-16

  2. Dendrimer-protein interactions versus dendrimer-based nanomedicine

    Colloids and Surfaces B: Biointerfaces, Vol. 152, pp. 414-422

  3. Gold nanoparticles stabilized by cationic carbosilane dendrons: Synthesis and biological properties

    Dalton Transactions, Vol. 46, Núm. 27, pp. 8736-8745

  4. Ruthenium metallodendrimers with anticancer potential in an acute promyelocytic leukemia cell line (HL60)

    European Polymer Journal, Vol. 87, pp. 39-47

2016

  1. Interaction between dendrimers and regulatory proteins. Comparison of effects of carbosilane and carbosilane-viologen-phosphorus dendrimers

    RSC Advances, Vol. 6, Núm. 100, pp. 97546-97554

2015

  1. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction

    International Journal of Pharmaceutics, Vol. 485, Núm. 1-2, pp. 261-269

  2. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action

    International Journal of Pharmaceutics, Vol. 485, Núm. 1-2, pp. 288-294